Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention Trial.

Cook ED, Arnold KB, Hermos JA, McCaskill-Stevens W, Moody-Thomas S, Probstfield JL, Hamilton SJ, Campbell RD, Anderson KB, Minasian LM.

Clin Trials. 2010 Feb;7(1):90-9. doi: 10.1177/1740774509357227.

2.

The potential for prostate cancer chemoprevention.

Brawley OW.

Rev Urol. 2002;4 Suppl 5:S11-7.

3.

Chemoprevention strategies in the prostate: an overview.

Kelloff GJ, Higley HR, Brawer MK, Lucia MS, Sigman CC, Crawford ED.

Rev Urol. 2002 Spring;4(2):69-77.

4.

Chemopreventive trials in urologic cancer.

Ashughyan VR, Marihart S, Djavan B.

Rev Urol. 2006 Winter;8(1):8-13.

5.

An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth.

Weihua Z, Lathe R, Warner M, Gustafsson JA.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13589-94. Erratum in: Proc Natl Acad Sci U S A. 2006 May 23;103(21):8298.

Supplemental Content

Support Center